Zobrazeno 1 - 10
of 10
pro vyhledávání: '"O N Koç"'
Publikováno v:
Oncogene. 15:2127-2132
We evaluated induction of lymphomas by the methylating carcinogen, N-methylnitrosourea [MNU], in transgenic mice expressing both LMO1 and the DNA repair gene, MGMT, in the thymus. The goal was to determine whether environmental mutagens shorten the l
Autor:
Nukhet Tuzuner, M Taşyürekli, Lamia Ulukutlu, Fügen Çullu, R A Seger, O N Koç, O N Ulutin, L Sağlamer, F Oz
Publikováno v:
Pediatrics International. 37:177-181
Multiple persistent vacuoles were seen in the neutrophils, monocytes and eosinophils of a 9 year old boy and his 10 year old sister. The siblings were both asymptomatic. In the bone marrow, the cytoplasmic vacuoles were also present in the promyelocy
Autor:
O. N. Koç
Publikováno v:
Genetic Engineering of Mesenchymal Stem Cells ISBN: 9781402039355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c8cc6a3db1d06e27535d77d6b48a5ff
https://doi.org/10.1007/1-4020-3959-x_9
https://doi.org/10.1007/1-4020-3959-x_9
Publikováno v:
Blood. 95(10)
The limited efficacy of hematopoietic gene therapy can be improved by in vivo selection for transduced long-term repopulating cells (LTRC). We selected for G156A MGMT (triangle upMGMT) transduced LTRC present in 5 x 10(4) to 100 x 10(4) marrow cells
Publikováno v:
Progress in experimental tumor research. 36
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(2)
Alkyltransferase (AGT) repairs alkylation at O6-guanine in DNA and is a major determinant of susceptibility to alkylating chemotherapeutic agents and carcinogens. Using a newly developed flow cytometry assay with the monoclonal anti-AGT antibody, mT3
Publikováno v:
Cancer research. 57(22)
A retroviral gene therapy approach was developed to protect early hematopoietic progenitors from 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), a stem cell toxin, and O6-benzylguanine (BG), an inhibitor of a key BCNU resistance protein, O6-alkylguanine
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 2(8)
Myelosuppression is the dose-limiting toxicity for nitrosourea chemotherapy due to low levels of the DNA repair protein O6-alkylguanine-DNA alkyltransferase in myeloid precursors. We have shown that high-efficiency myeloproliferative sarcoma virus (v
Publikováno v:
Seminars in oncology. 23(1)
A number of drug resistance genes have been identified that may be useful in gene therapy approaches to ameliorate chemotherapy toxicity. Hematopoietic tissue is the most suitable target for drug resistance gene therapy because myelosuppression is th
Publikováno v:
Cancer treatment and research. 87
The mechanism of cytotoxicity of a number of chemotherapeutic agents involves alkylation at the O6 position of guanine, a site that strongly influences cytotoxicity. Repair of these lesions by the alkyltransferase protects from cytotoxicity and is a